In addition, approximately half of chondrosarcoma cases carry an IDH1 or IDH2 mutation, and therefore mutational testing can be helpful to verify the diagnosis and to exclude chondroblastic osteosarcoma (3). Here, IDH2 is linked to chondrosarcoma.